- Investors may be wondering whether Ingredion at around US$103.96 is starting to look like a bargain, or if the recent slide is a signal to be cautious.
- The stock has risen 3.2% over the past week, but is down 8.0% over the last 30 days, 5.3% year to date, and 22.6% over the past year. This may reflect shifting views on its growth potential and risk.
- Recent coverage has focused on how Ingredion fits into broader conversations about consumer demand trends and cost pressures in the food ingredients sector, as investors reassess which companies might be better positioned for changing customer preferences. These themes help frame why the share price has been under pressure over the past year while still seeing short term rebounds.
- On Simply Wall St's valuation checks, Ingredion scores a 5 out of 6. The rest of this article will walk through what that means across different valuation methods and introduce a broader way of thinking about value that ties them all together by the end.
Find out why Ingredion's -22.6% return over the last year is lagging behind its peers.
Approach 1: Ingredion Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting the cash the company may generate in the future and discounting those cash flows back to today using a required return. Simply Wall St uses a 2 Stage Free Cash Flow to Equity model for Ingredion.
Ingredion's latest twelve month Free Cash Flow is about $554.6 million. Based on analyst input and extrapolations by Simply Wall St, projected Free Cash Flow is $516 million in 2028, with a series of annual forecasts stepping through the next decade. These projections, all in $, are discounted back to present value and combined with a terminal value to arrive at an estimated intrinsic value per share of about $197.82.
Set against the recent share price of about $103.96, this DCF output suggests Ingredion is trading at a 47.4% discount to that intrinsic estimate, which indicates the stock appears undervalued on this specific model.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Ingredion is undervalued by 47.4%. Track this in your watchlist or portfolio, or discover 46 more high quality undervalued stocks.
Approach 2: Ingredion Price vs Earnings
For profitable companies, the P/E ratio is a useful yardstick because it links what you are paying directly to the earnings the company is generating today. Investors usually accept a higher or lower P/E depending on what they expect for future growth and how much risk they see in those earnings.
Ingredion currently trades on a P/E of about 9.7x. That sits below the Food industry average P/E of roughly 19.3x and also below the broader peer group average of about 33.5x. On simple comparisons, the stock looks inexpensive against both its sector and peers.
Simply Wall St’s Fair Ratio for Ingredion is 16.9x. This is a proprietary estimate of what a more “normal” P/E could be, taking into account factors such as earnings growth, industry, profit margins, market capitalization and company specific risks. Because it blends these company traits rather than just lining Ingredion up against a broad peer or industry average, the Fair Ratio can give a more tailored reference point.
Comparing the current P/E of 9.7x with the Fair Ratio of 16.9x suggests the stock is trading below that customised benchmark on this metric.
Result: UNDERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.
Upgrade Your Decision Making: Choose your Ingredion Narrative
Earlier it was mentioned that there is an even better way to understand valuation. Narratives bring this to life by letting you attach a clear story about Ingredion to your own assumptions for future revenue, earnings and margins, then linking that story to a forecast and a fair value that you can compare with the current price.
On Simply Wall St’s Community page, Narratives are an easy tool that many investors already use. You can see different fair value estimates for Ingredion in one place, understand the story and key assumptions behind each one, and then decide how comfortable you are with those views.
For example, one investor might build an optimistic Ingredion Narrative that aligns more with the US$140 analyst target, based on confidence in health and affordability trends and higher long term earnings. Another might prefer a cautious Narrative closer to US$110 that focuses on risks such as LATAM pressures, trade friction and legacy product demand. Both Narratives will automatically refresh when new earnings, guidance or news are added, so you can continually reassess how fair value compares with the live share price.
Do you think there's more to the story for Ingredion? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com